OAM
AGN

Orinda Asset Management’s Allergan plc AGN Stock Holding History

Orinda Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$144K – 165
2013
Q3 		$144K Buy
+1,000
New +$133K 0.45% 80

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Orinda Asset Management's AGN Position: Q4 2013 in Review

Orinda Asset Management sold out of Allergan plc (AGN) in Q4 2013, closing a stake of 1,000 shares — an estimated $144K sold.

Orinda Asset Management first reported a position in AGN in Q3 2013 and held it in 1 quarter. The position peaked at $144K in Q3 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Orinda Asset Management reported no remaining Allergan plc position as of Q4 2013 after selling out during the quarter.
  • Orinda Asset Management sold 1,000 Allergan plc shares in Q4 2013, an estimated $144K.
  • Orinda Asset Management first reported a position in Allergan plc in Q3 2013 and held it in 1 quarter.
  • Orinda Asset Management's Allergan plc position peaked at $144K in Q3 2013.
  • 552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on Orinda Asset Management's 13F filing for Q4 2013, filed 3 Feb 2014.